FDA Approved: TRIDESILON CREAM — Supplemental Application (Encore Dermatology Inc)

View source ↗

Summary

FDA approved a supplemental application for Tridesilon Cream (desonide 0.05%), updating the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis
• Contact Dermatitis
• Seborrheic Dermatitis

Drugs mentioned

• TRIDESILON CREAM (Desonide 0.05%)

Snippet

SUPPL AP for TRIDESILON CREAM (DESONIDE 0.05%)